As I write this, noise fills my house: the nail gun, the power saw, and the construction workers’ radio. I can feel my hard-earned routine for living with Friedreich’s ataxia (FA) slipping out of reach. I keep reminding myself that each bang and disruption brings us closer to an…

My family, including my parents, recently took a grand vacation. We started in West Yellowstone in Montana, where we watched a juvenile black bear hunt a squirrel, swim across a river, dig for grubs in a downed tree, and relax in the sun. We also saw waterfalls, canyons, thermal pools,…

Genetic mutations that cause Friedreich’s ataxia (FA) arise from a previously unrecognized category of FXN gene variants called a protomutation, according to a study. The protomutation was found exclusively in people of Eurasian descent and explains why the disease has always been limited to those populations. “These findings define…

A couple of weekends ago, someone said something I hear all too often: “You are so lucky to be able to bring your dog with you.” I know they meant it kindly, but my first thought was, “Lucky?” Wendy is not just my dog. She is my service dog.

Larimar Therapeutics has begun the process of asking the U.S. Food and Drug Administration (FDA) to grant accelerated approval to nomlabofusp, its protein replacement therapy for Friedreich’s ataxia (FA). Typically, drug developers seeking a therapy’s approval need to finish the entire application before submitting it to the FDA.